Oncologic Drugs Advisory Committee (ODAC)

First Page		Document Content
Medicine Purines Clinical pharmacology United States Public Health Service New Drug Application FDA Fast Track Development Program Cetuximab Clofarabine Nelarabine Food and Drug Administration Pharmacology Pharmaceutical sciences		Oncologic Drugs Advisory Committee (ODAC) Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 2,68 MB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BELEODAQ safely and effectively. See full prescribing information for BELEODAQ. BELEODAQ® (belinostat) for injectio DocID: 1gmOO - View Document
	Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID, 4 pages http://dx.doi.orgCase Report DocID: 11yNp - View Document
	ALLG Safety and Data Monitoring Committee DocID: XWBD - View Document
	Microsoft Word - DAC 2013Q4 meeting outcome_Eng.docx DocID: Thhc - View Document
	clofarabine Advisory Note DocID: TfOV - View Document